Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SS) SHH

42.60

-1.35(-3.07%)

Updated at January 14 03:00PM

Currency In CNY

Valuation

Market Cap8.08B
Enterprise Value8.96B
P/E Ratio-17.96
PEG Ratio-1.03
Price/Sales Ratio27.26
Price/Book Ratio22.35
Enterprise/Revenue29.15
Enterprise/EBITDA-22.7

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-1.52
Operating Margin-1.46

Management Effectiveness

Return On Assets-0.21
Return On Equity-0.86

Income Statement

Revenue199.78M
Revenue/Share1.56
Gross Profit165.3M
EBITDA-930.36M
Net Income-1.04B
Diluted EPS-2.61

Balance Sheet

Total Cash1.48B
Total Cash/Share3.71
Total Debt2.63B
Total Debt/Equity3.45
Current Ratio0.9
Book Value Per Share2.37

Price History

52-Week Change136.14
52-Week High63.59
52-Week Low15.36
Moving Average 50 Days41.74
Moving Average 200 Days36.35

Statistics

Average Volume7.63M
Shares Outstanding399.6M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.07
Last Split FactorN/A
Last Split DateN/A